142 related articles for article (PubMed ID: 1092531)
1. Response of patients with chronic obstructive lung disease to the regular administration of nebulized isoproterenol. A double-blind crossover study.
Light RW; Summer WR; Luchsinger PC
Chest; 1975 Jun; 67(6):634-9. PubMed ID: 1092531
[TBL] [Abstract][Full Text] [Related]
2. Regional lung function and over-all gas exchange in chronic obstructive lung disease: the effect of intermittent positive pressure breathing with isoproterenol.
Dawson A; Rocamora JM
Am Rev Respir Dis; 1974 Mar; 109(3):338-44. PubMed ID: 4592451
[No Abstract] [Full Text] [Related]
3. A double-blind parallel study of acetylcysteine-isoproterenol and saline-isoproterenol in patients with chronic obstructive lung disease.
Cato A; Goldstein I; Millman M
J Int Med Res; 1977; 5(3):175-83. PubMed ID: 330289
[TBL] [Abstract][Full Text] [Related]
4. Simple ventilatory tests for assessing response to bronchodilator in chronic obstructive pulmonary disease.
Sobol BJ; Emirgil C; Wadhwani B; Goyal P
Anesth Analg; 1972; 51(1):21-6. PubMed ID: 5061719
[No Abstract] [Full Text] [Related]
5. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
[TBL] [Abstract][Full Text] [Related]
6. Nebulized bronchodilators in obstructive lung disease. II.
Sheldon GP
Ann Allergy; 1972 Feb; 30(2):69-85. PubMed ID: 4551435
[No Abstract] [Full Text] [Related]
7. Cardiac and pulmonary effects of therapy with albuterol and isoproterenol.
Whitsett TL; Manion CV
Chest; 1978 Sep; 74(3):251-5. PubMed ID: 357097
[TBL] [Abstract][Full Text] [Related]
8. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
Geraghty R; Foster C; Black D; Roe S
Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
[TBL] [Abstract][Full Text] [Related]
10. The distribution of nebulized isoproterenol and its effect of regional ventilation and perfusion.
Dashe CK; Ponto RA; Ganapes CM; Drage CW; Kronenberg RS
Am Rev Respir Dis; 1974 Sep; 110(3):293-300. PubMed ID: 4607176
[No Abstract] [Full Text] [Related]
11. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
12. Comparison of isoproterenol and isoproterenol-phenylephrine aerosols.
Grant JL; Werfelman N; Cook MR; Metherall W
Chest; 1971 Aug; 60(2):129-32. PubMed ID: 5571471
[No Abstract] [Full Text] [Related]
13. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
Stănescu DC; Clément J; Van de Woestijne KP
Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
[No Abstract] [Full Text] [Related]
14. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
el-Naggar M; Collins VJ
Crit Care Med; 1974; 2(2):82-5. PubMed ID: 4832285
[No Abstract] [Full Text] [Related]
15. Studies on the pulmonary physiological effect of sympathomimetic amines in bronchial asthma.
Crosbie WA; Kidner PH; Miller JN; Pride NB
J Asthma Res; 1971 Mar; 8(3):99-110. PubMed ID: 4932130
[No Abstract] [Full Text] [Related]
16. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
Chatterjee SS; Dinda P; Riding WD
Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
[No Abstract] [Full Text] [Related]
17. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD.
Girault C; Muir JF; Mihaltan F; Borderies P; De La Giclais B; Verdure A; Samson-Dollfus D
Chest; 1996 Nov; 110(5):1203-11. PubMed ID: 8915222
[TBL] [Abstract][Full Text] [Related]
18. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease.
Pennock BE; Rogers RM; Ryan BR; Ayers LN
Chest; 1977 Dec; 72(6):731-6. PubMed ID: 336306
[TBL] [Abstract][Full Text] [Related]
19. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
20. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
